Sarcodon aspratus-based Solutions for Niche Gynecological Needs

Publication ID: 24-11857586_0009_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Sarcodon aspratus-based Solutions for Niche Gynecological Needs,” Published Technical Disclosure No. 24-11857586_0009_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857586_0009_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,586.

Summary of the Inventive Concept

The inventive concept adapts the original pharmaceutical composition containing Sarcodon aspratus extracts for specific, underserved markets and operational environments, such as high-altitude regions, areas with limited medical access, and high-stress occupations.

Background and Problem Solved

The original patent provided a general solution for preventing or treating gynecological diseases using Sarcodon aspratus extracts. However, it did not address the unique challenges faced by women in niche environments, such as high-altitude regions where low oxygen levels exacerbate gynecological issues, areas with limited access to medical care, or high-stress occupations that can disrupt hormonal balance.

Detailed Description of the Inventive Concept

The inventive concept comprises a system, method, or pharmaceutical composition tailored to the specific needs of women in these niche environments. For high-altitude regions, the composition is formulated to mitigate the effects of low oxygen levels. For areas with limited medical access, the functional health food is packaged in a portable, shelf-stable format. For women with compromised immune systems, the extracts are formulated to enhance immune function and reduce the risk of infection. For areas prone to natural disasters, the system includes a portable, waterproof container. For high-stress occupations, the functional health food is formulated to reduce stress and promote overall well-being.

Novelty and Inventive Step

The inventive concept's novelty lies in its adaptation of the original pharmaceutical composition to address specific, underserved markets and operational environments, resulting in a unique combination of Sarcodon aspratus extracts and specialized formulations. The inventive step is the recognition of these niche needs and the development of targeted solutions.

Alternative Embodiments and Variations

Alternative embodiments may include customized packaging for specific environments, additional ingredients to enhance the composition's effectiveness, or alternative delivery methods, such as transdermal patches or suppositories.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the gynecological health market, particularly in regions with high-altitude environments, areas with limited access to medical care, and industries with high-stress occupations. The target industries include pharmaceutical, functional health food, and medical device manufacturers.

CPC Classifications

SectionClassGroup
A A61 A61K36/07
A A61 A61K9/0056
A A61 A61P15/08
A A61 A61K2236/333

Field of Art

Pharmaceutical compositions for women's health, specifically gynecological disease treatment, with expertise in herbal extracts, functional health foods, and targeted medical formulations

Person of Ordinary Skill (PHOSITA) Profile

A professional with advanced training in pharmaceutical sciences, herbal medicine, and women's health, capable of understanding extract formulation, medical adaptation, and product design for specific health conditions

Obviousness Rationale

A PHOSITA would recognize that the source patent's Sarcodon aspratus extracts provide a foundational therapeutic approach that can be readily adapted to specific environmental and physiological contexts. The PTD's variations represent predictable extensions of the original pharmaceutical composition by applying known formulation techniques to address niche market needs. The core therapeutic mechanism remains consistent, with modifications representing standard design choices in pharmaceutical development.

Obvious Combinations & Variations

Source Patent Element
Pharmaceutical composition containing Sarcodon aspratus extracts for treating gynecological diseases
PTD Variation
Formulation specifically adapted for high-altitude environments to mitigate low oxygen effects
Obviousness Reasoning
Adjusting pharmaceutical compositions for specific physiological conditions is a standard practice in drug development, representing a predictable variation using known pharmacological techniques
Source Patent Element
Functional health food with Sarcodon aspratus extracts
PTD Variation
Portable, shelf-stable packaging for areas with limited medical access
Obviousness Reasoning
Modifying product packaging and stability for different distribution environments is a routine design choice in pharmaceutical and nutraceutical product development
Source Patent Element
Gynecological disease treatment using herbal extracts
PTD Variation
Immune system enhancement formulation for patients with compromised immunity
Obviousness Reasoning
Adapting herbal extract compositions to target specific physiological conditions represents a standard approach in personalized medical formulation
Source Patent Element
Pharmaceutical composition for gynecological health
PTD Variation
Stress reduction formulation for high-stress occupational environments
Obviousness Reasoning
Tailoring herbal extract compositions to address specific stress-related health challenges is a predictable extension of existing therapeutic approaches
Source Patent Element
Sarcodon aspratus extract-based health composition
PTD Variation
Waterproof, disaster-resistant packaging for challenging environmental conditions
Obviousness Reasoning
Developing specialized packaging for medical products in extreme conditions represents a standard engineering adaptation in pharmaceutical product design
35 U.S.C. § 103 Summary: Based on US Patent 11857586, the present publication demonstrates that the claimed variations in pharmaceutical composition design, packaging, and targeted formulation represent obvious extensions of the prior art, rendering subsequent claims involving similar adaptations anticipated and non-patentable under standard obviousness analysis. The disclosed variations constitute predictable technical modifications within the ordinary skill of practitioners in pharmaceutical and herbal medicine development.

Original Patent Information

Patent NumberUS 11,857,586
TitlePharmaceutical composition for preventing or treating gynecological diseases containing Sarcodon aspratus extracts as active ingredient